Drug & supplement interaction

Levilactobacillus Brevis + Enfortumab Vedotin-Ejfv

Enfortumab Vedotin-Ejfv brand name: Padcev.

No Known Interaction
Medically reviewed by · Updated July 2026 · Pair last verified Sep 13, 2026
The bottom line No known interaction

We found no known interaction between Levilactobacillus Brevis and Enfortumab Vedotin-Ejfv in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

Levilactobacillus Brevis and Enfortumab Vedotin-Ejfv

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Enfortumab Vedotin-Ejfv and Levilactobacillus Brevis in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Levilactobacillus Brevis safety at a glance

Levilactobacillus... overall Use caution Generally well tolerated in healthy people, but people who are seriously ill or immunocompromised should be cautious.
Pregnancy Use caution Not enough reliable safety data; talk to your doctor before using during pregnancy.
Breastfeeding Use caution Limited data on use while breastfeeding; check with your doctor or pharmacist first.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Enfortumab Vedotin-Ejfv and Levilactobacillus Brevis? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Enfortumab Vedotin-Ejfv

Interactions in our licensed database are recorded against drug classes, not just single drug names. Enfortumab Vedotin-Ejfv is filed under a single classification — cytochrome p450 3a4 (cyp3a4) substrates. Levilactobacillus Brevis has documented interactions with 1 drug class — the most serious being antibiotic drugs (moderate) — and none of Enfortumab Vedotin-Ejfv’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Levilactobacillus Brevis Does Interact With Other Medications

Levilactobacillus Brevis has 182 moderate known drug interactions in our database — Enfortumab Vedotin-Ejfv isn’t one of them. If you take anything else, check it against the full list below.

Moderate 182 No known interaction 2,648 (incl. Enfortumab Vedotin-Ejfv)
Taking anything else?

Check Another of Your Medications Against Levilactobacillus Brevis

Covers the 2,830 medications we’ve checked against Levilactobacillus Brevis. Pick one to open its full report.

What to actually watch for

What Levilactobacillus Brevis Itself Has Been Linked To

This is not an interaction — nothing below involves Enfortumab Vedotin-Ejfv. It is the side-effect record for Levilactobacillus Brevis on its own, from the licensed Natural Medicines monograph. If something new turns up after you add Levilactobacillus Brevis, this list is the first place to look. One entry is worth acting on rather than waiting out — marked below.

  • A higher chance of infection Worth acting on Additional detail

    “Since Levilactobacillus brevis preparations contain live and active microorganisms, there is some concern that they might cause pathogenic infection in some patients. Some lactobacilli species have been isolated in cases of bacteremia, sepsis, splenic abscess, endocarditis, necrotizing fasciitis, pancreatic necrosis, and meningoencephalitis.”

    Levilactobacillus Brevis · Natural Medicines adverse-effect record, reported in sepsis.

    1 source cited
    1. 107543. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed
  • Diarrhea / Nausea Additional detail

    “Orally, taking Levilactobacillus brevis has rarely caused nausea, abdominal fullness, or mild diarrhea, in clinical research.”

    Levilactobacillus Brevis · Natural Medicines adverse-effect record, reported in diarrhea.

    2 sources cited
    1. 110959. Tasli L, Mat C, De Simone C, Yazici H. Lactobacilli lozenges in the management of oral ulcers of Behçet's syndrome. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S83-6.
    2. 110962. Silva NLNV, Della Bona A, Cardoso M, et al. Lactobacillus brevis CD2 attenuates traumatic oral lesions induced by fixed orthodontic appliance: A randomized phase 2 trial. Orthod Craniofac Res. 2021;24(3):379-385.

Everything above comes from the Natural Medicines adverse-effect record for Levilactobacillus Brevis — expand a row for the licensed statement it rests on. We haven’t matched Enfortumab Vedotin-Ejfv to its FDA label in our system yet, so we can’t compare its own side-effect list here — the leaflet that comes with your prescription is the authoritative list for Enfortumab Vedotin-Ejfv.

Everything else you take

See Every Supplement That Interacts With Enfortumab Vedotin-Ejfv

This page covers Levilactobacillus Brevis only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Enfortumab Vedotin-Ejfv page lists 121 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate), Adrafinil (moderate) and African Wild Potato (moderate).

By severity: 2 major · 87 moderate · 32 minor.

From our pharmacist’s overview on the Enfortumab Vedotin-Ejfv page

“If you are getting Padcev (enfortumab vedotin) infusions for bladder cancer, treat this page as one worth genuine attention. The chemotherapy payload in Padcev is cleared by a liver enzyme called CYP3A4, and all 121 ingredients listed here act on that enzyme, either blocking it so the drug builds up or speeding it up so treatment weakens.”

Reviewed by 2 · Jul 18, 2026

Open the Enfortumab Vedotin-Ejfv interaction page

How much people look this up

Where Levilactobacillus Brevis and Enfortumab Vedotin-Ejfv Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Levilactobacillus Brevis
Steady interest

#778 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Enfortumab Vedotin-Ejfv
Top 25%

#384 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Levilactobacillus Brevis reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Levilactobacillus Brevis and Enfortumab Vedotin-Ejfv records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Levilactobacillus Brevis

What is Levilactobacillus Brevis?

  • Digestive health
  • Gut microbiome support
  • Immune support
  • Oral and dental health
  • Vaginal health

Levilactobacillus brevis (formerly Lactobacillus brevis) is a lactic acid bacterium found in fermented foods like sauerkraut, pickles, and kimchi, and is used as a probiotic. Early research suggests possible benefits for gut and immune health, but strong human evidence is still limited. It is generally well tolerated in healthy people, but anyone with a weakened immune system or serious illness should talk to a doctor first.

Levilactobacillus brevis · Lactobacillaceae · Whole live bacteria (probiotic strain) · Capsules, tablets, powders, fermented foods, and combination probiotic products

An interaction check asks whether these two react with each other — it does not ask whether Levilactobacillus Brevis is a good idea for someone in your situation. Here is what our Levilactobacillus Brevis record says about it on its own.

Levilactobacillus Brevis: dosing

There is no official standardized dose for Levilactobacillus brevis. Probiotic amounts are usually measured in colony-forming units (CFU), and products vary widely in strength and strain.The best approach is to follow the directions on the product label. Doses are often taken once or twice daily, sometimes with food.

From our Levilactobacillus Brevis monograph — the full record covers uses, side effects and every documented interaction.

Read the full Levilactobacillus Brevis monograph & all interactions
Medication

About Enfortumab vedotin-ejfv Injection

What Is Enfortumab vedotin-ejfv Injection Used For?

Brand name: Padcev

  • Enfortumab vedotin-ejfv injection is used to treat urothelial cancer (cancer of the lining of the bladder and other parts of the urinary tract) that has spread to nearby tissues or other parts of the body or cannot be removed by surgery, and has worsened after treatment with other chemotherapy medications or if these chemotherapy medications cannot be used for treatment. Enfortumab vedotin-ejfv injection is in a class of medications called monoclonal antibodies. It works by helping your immune system to slow or stop the growth of cancer cells.

See full Enfortumab vedotin-ejfv Injection drug information
Keep checking

Other Drugs & Levilactobacillus Brevis

Browse every other medication we’ve checked against Levilactobacillus Brevis — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
182Moderate
0Minor
2,647No known interaction
182 Moderate 2,647 No interaction
Moderate

182 interactions

Showing 60 of 182 moderate interactions — see all 182 on the Levilactobacillus Brevis page.

No interaction 2,647 drugs checked — show the list

We also checked Levilactobacillus Brevis against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,647 medications checked with no known interaction — see the full Levilactobacillus Brevis list.

See the full Levilactobacillus Brevis interactions page
See every supplement checked against Enfortumab Vedotin-Ejfv, ranked by severity
Evidence & sources

Levilactobacillus Brevis References

The 4 references that drive our Levilactobacillus Brevis monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed
  3. Tasli L, Mat C, De Simone C, Yazici H. Lactobacilli lozenges in the management of oral ulcers of Behçet's syndrome. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S83-6.
  4. Silva NLNV, Della Bona A, Cardoso M, et al. Lactobacillus brevis CD2 attenuates traumatic oral lesions induced by fixed orthodontic appliance: A randomized phase 2 trial. Orthod Craniofac Res. 2021;24(3):379-385.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Levilactobacillus Brevis and Enfortumab Vedotin-Ejfv Together: Common Questions

Is it safe to take Levilactobacillus Brevis with Enfortumab Vedotin-Ejfv?
We do not list a known interaction between Levilactobacillus Brevis and Enfortumab Vedotin-Ejfv. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
How was the Levilactobacillus Brevis and Enfortumab Vedotin-Ejfv combination checked?
Interactions in our licensed database are recorded against drug classes. Enfortumab Vedotin-Ejfv is filed under 1 classification, and Levilactobacillus Brevis has documented interactions with 1 drug class — none of Enfortumab Vedotin-Ejfv's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Levilactobacillus Brevis interact with any other medications?
Yes. Levilactobacillus Brevis has 182 documented drug interactions in our database — Enfortumab Vedotin-Ejfv is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Enfortumab Vedotin-Ejfv interact with any supplements?
Yes. Enfortumab Vedotin-Ejfv has documented interactions with 121 supplements in our database — Levilactobacillus Brevis is not one of them. The Enfortumab Vedotin-Ejfv interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Levilactobacillus Brevis monograph Uses, safety profile, and every drug interaction in one place Enfortumab vedotin-ejfv Injection drug information The full plain-English guide to this medication Enfortumab Vedotin-Ejfv supplement interactions Every supplement checked against Enfortumab Vedotin-Ejfv, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 4 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Enfortumab Vedotin-Ejfv and Levilactobacillus Brevis?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.